Severity Score News Today

Hypnosis, mindfulness meditation, and cognitive-behavioral therapy have shown particular benefits in irritable bowel syndrome.

In this investigation, outcomes of interest were morbidity rate and length of hospital stay or a traumatic injury among a homeless population, and whether age and/or injury severity had an influence on that relationship—with implications for improving the discharge process for these patients.

– STRIDE Phase 2 primary endpoint of PASI 75 and key secondary endpoints met at all clinically relevant doses tested; sustained maximal target inhibition safely achieved at top dose –

Alumis today announced the presentation of positive clinical data from a Phase 2 clinical trial of ESK-001 at AAD 2024....

Remibrutinib, an investigational, highly selective Bruton tyrosine kinase inhibitor, showed favorable results in the treatment of chronic spontaneous urticaria (CSU) in as early as 2 weeks in the phase 3 REMIX-1 and REMIX-2 studies.

A new study in those with IBS observes that participants with more diverse gut microbiomes at baseline have significantly improved gut symptoms and quality of life scores following a fibre intervention, compared to those with lower diversities.

There has been a slogan that has circulated on social media recently that goes like this: “Fall is proof that change is beautiful.” Hmm… I suppose

James Neal Russell and colleagues report a global neonatal sepsis observational cohort study (NeoOBS) exploring patterns of antibiotic use, pathogens and prediction of mortality in hospitalised neonates and young infants with sepsis.

Additional validation studies are needed, but these tools may improve clinical management.

Several digital tools — available as smartphone apps or web-based platforms — could help patients with irritable bowel syndrome, according to a new study published in the American Journal of Gastroenterology.